FDA Approved: NEOSTIGMINE METHYLSULFATE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Neostigmine Methylsulfate submitted by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

SUPPL AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)